Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Apremilast did not work for treating severe alopecia areata.

Dupilumab helps children with alopecia areata regrow hair safely.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.